Section 1: Physical morbidity

(1.1) Section 1: Physical morbidity

(1.2) Physical morbidity

(1.3) Treatment of medical disease in people with SMI

(1.4) Medical care

(1.5) Reflection

(1.6) Section 1: Recap

(1.5) Section 1: Summary

Section 2: Obesity, diabetes and the metabolic syndrome

(2.1) Section 2: Obesity, diabetes and the metabolic syndrome

(2.2) Weight gain and obesity

(2.3) Weight monitoring

(2.4) Diabetes

(2.5) Glucose

(2.5) Glucose monitoring

(2.6) The metabolic syndrome

(2.7) Monitoring the metabolic syndrome

(2.8) Reflection

(2.9) Section 2: Recap

(2.10) Section 2: Summary

Section 3: Morbidity through contra-indications

(3.1) Section 3: Sexual dysfunction and elevated prolactin levels

(3.2) Sexual dysfunction and elevated prolactin levels

(3.3) Monitoring prolactin

(3.4) Extrapyramidal side effects (EPSEs)

(3.5) Monitoring EPSEs

(3.6) Cardiac effects and QT prolongation

(3.7) Monitoring cardiac problems

(3.8) Reflection

(3.9) Section 3: Recap

(3.10) Section 3: Summary

Section 4: Smoking, drug and alcohol misuse

(4.1) Smoking, drug and alcohol misuse

(4.2) Cigarette smoking

(4.3) Drug and alcohol misuse

(4.4) Drug-related health issues

(4.5) Monitoring substance use issues

(4.6) Reflection

(4.7) Section 4: Recap

(4.8) Section 4: Interactive activity

(4.9) Section 4 Summary

Section 5: Medication

(5.1) Medication

(5.2) Choice of treatment

(5.3) Choice of treatment

(5.4) Prescribing advice

(5.5) Section 5: Recap

(5.4) Section 5: Summary

Module summary

Module test

References

Further reading

Take-home notes

Send feedback

Annual revisions

Annual revisions